No Results Found
The posts you requested could not be found. Try changing your module settings or create some new posts.
HEALTH
Two years in, the Inflation Reduction Act is lowering health care costs and creating a clean energy jobs boom in North Carolina
| August 16, 2024
The Inflation Reduction Act ensured that 135,000 North Carolinians were able to keep their health insurance, reduced the cost of insulin for nearly 57,000 North Carolina seniors, and incentivized manufacturers to invest in the state and create more clean energy jobs.
Biden-Harris administration’s Medicare drug price negotiations secure $6 billion in savings for taxpayers
| August 15, 2024
The White House estimates that these new prices will lead to around $6 billion in savings for the Medicare program in 2026. The new prices will be anywhere from 38% to 79% lower than the drugs’ list prices last year, saving seniors on Medicare an estimated $1.5 billion in out-of-pocket costs in 2026 alone.
Dozens of pregnant women, some bleeding or in labor, being turned away from ERs despite federal law
| August 12, 2024
2024 ELECTIONS | ABORTION | HEALTH | HEALTHCARE | NATIONAL NEWS | national politics | women's health
Even as the Biden administration publicly warned hospitals to treat pregnant patients in emergencies, facilities continue to violate the federal law. The issue became a focus for the administration following reports of women being improperly treated in emergency rooms after the Supreme Court’s decision to overturn the constitutional right to an abortion more than two years ago.
Insulin price cuts for 154,000 North Carolina seniors through Biden-Harris initiative
| August 10, 2024
As a result of the Biden-Harris administration’s Inflation Reduction Act, Medicare recipients now pay no more than $35 a month for insulin. Carrol Olinger was panicking. It was 2022, and the retired Fayetteville teacher — disabled and between jobs — relied on Medicare to help pay for insulin to treat her type 1 […]
Major drugmakers capped cost of asthma inhalers at $35 per month after investigation from Democrats
| August 7, 2024
AstraZeneca, Boehringer Ingelheim, and GlaxoSmithKline all agreed to cap the price of asthma inhalers earlier this year following an investigation by a Democratic-led Senate Committee.